Family involvement in cancer treatment decision-making: A qualitative study of patient, family, and clinician attitudes and experiences

2016 ◽  
Vol 99 (7) ◽  
pp. 1146-1155 ◽  
Author(s):  
Rebekah Laidsaar-Powell ◽  
Phyllis Butow ◽  
Stella Bu ◽  
Cathy Charles ◽  
Amiram Gafni ◽  
...  
Keyword(s):  
Decision Making ◽  
Qualitative Study ◽  
Cancer Treatment ◽  
Family Involvement ◽  
Treatment Decision ◽  
Treatment Decision Making ◽  
Clinician Attitudes

Attitudes Toward Family Involvement in Cancer Treatment Decision Making: The Perspectives of Patients, Family Caregivers, and Their Oncologists

2016 ◽  
Vol 26 (6) ◽  
pp. 770-778 ◽  
Author(s):  
Dong Wook Shin ◽  
Juhee Cho ◽  
Debra L. Roter ◽  
So Young Kim ◽  
Hyung Kook Yang ◽  
...  
Keyword(s):  
Decision Making ◽  
Cancer Treatment ◽  
Family Caregivers ◽  
Family Involvement ◽  
Treatment Decision ◽  
Treatment Decision Making

Preferences for and experiences of family involvement in cancer treatment decision-making: patient-caregiver dyads study

2013 ◽  
Vol 22 (11) ◽  
pp. 2624-2631 ◽  
Author(s):  
Dong Wook Shin ◽  
Juhee Cho ◽  
Debra L. Roter ◽  
So Young Kim ◽  
Sang Kyun Sohn ◽  
...  
Keyword(s):  
Decision Making ◽  
Cancer Treatment ◽  
Family Involvement ◽  
Treatment Decision ◽  
Treatment Decision Making

The Significance of Patient-Reported Outcomes for Metastatic Breast Cancer Patients

2022 ◽  
Author(s):  
Larissa Elisabeth Hillebrand ◽  
Ulrike Söling ◽  
Norbert Marschner
Keyword(s):  
Breast Cancer ◽  
Decision Making ◽  
Metastatic Breast Cancer ◽  
Cancer Treatment ◽  
Patient Reported Outcomes ◽  
Metastatic Breast ◽  
Treatment Decision ◽  
Breast Cancer Patients ◽  
Treatment Decision Making ◽  
Patient Reported

Background: Breast cancer is still the most common malignancy in women worldwide. Once metastasized, breast cancer treatment primarily aims at reducing symptom burden, thereby trying to maintain and improve a patient´s quality of life (QoL), delaying disease progression, and prolonging survival. Curing the disease is not possible in the palliative setting. To better understand metastatic breast cancer patients, their symptoms and wishes, which are important for treatment-decision making and outcome, patient-reported outcomes (PROs) are of great importance, giving an impression of what really matters to and concerns a patient. Summary: Many advances have been made to implicate PROs in clinical trials, non-interventional studies, registries, and clinical routine care of metastatic breast cancer. For example, large phase III trials like PALOMA-3 (NCT01942135), MONALEESA-7 (NCT02278120), HER2CLIMB (NCT02614794), and KEYNOTE-119 (NCT02555657) trials implemented PROs in their trial design to assess the QoL of their trial patients. Also, non-interventional studies on metastatic breast cancer, like e.g., the NABUCCO study (IOM-02240), and prospective non-interventional, multicenter registries e.g., the tumor registry breast cancer (NCT01351584) or the breast cancer registry platform OPAL (NCT03417115), have implemented PROs to assess QoL during the anti-cancer treatment periods of the patients. Key Message: Using PROs in metastatic breast cancer can support shared treatment-decision making and management of symptoms, eventually leading to an improvement in QoL. Progressively, regulatory authorities take PROs into consideration for the approval of new drugs. Hence, the implication of PROs in cancer treatment, and especially in MBC, is of significant value.

scholarly journals Perceived importance of affective forecasting in cancer treatment decision making

2020 ◽  
Vol 38 (6) ◽  
pp. 687-701
Author(s):  
Laura M. Perry ◽  
Michael Hoerger ◽  
Brittany D. Korotkin ◽  
Paul R. Duberstein
Keyword(s):  
Decision Making ◽  
Cancer Treatment ◽  
Treatment Decision ◽  
Affective Forecasting ◽  
Treatment Decision Making ◽  
Perceived Importance
Sign in / Sign up

Export Citation Format

Share Document